Calibrators & Controls

Tumor Marker Reagents

HUMAN’s tumor marker reagents deliver reliable solutions for the quantification of key oncology biomarkers, including alpha-fetoprotein (AFP), cancer antigens CA 125, CA 15-3, CA 19-9, carcinoembryonic antigen (CEA), and prostate-specific antigens (PSA and fPSA). These assays support the diagnosis, prognosis, and treatment monitoring of various malignancies, including hepatocellular carcinoma, ovarian, breast, pancreatic, and prostate cancers. Calibrated to international standards such as WHO, these reagents ensure precise measurements and compatibility with advanced laboratory systems, enhancing the efficiency and accuracy of oncology diagnostics.

Clear all
  • Tumor Marker

14 Items are shown

Quantitative determination of alpha-Fetoprotein

Quantitative determination of alpha-fetoprotein
​​​​​​​​​​​​​​​​​​​​​Remark: WHO Calibration

Quantitative determination of cancer antigen 125

Quantitative determination of carbohydrate antigen 125

Quantitative determination of cancer antigen 15-3

Quantitative determination of carbohydrate antigen 15-3

Quantitative determination of cancer antigen 19-9

Quantitative determination of carbohydrate antigen 19-9
Quantitative determination of carcinoembryonic antigen
​​​​​​​​​​​​​​​​​​​​​​​​​​​​Remark: WHO Calibration

Quantitative determination of carcinoembryonic antigen

Quantitative determination of free prostate specific antigen

Quantitative determination of free prostate specific antigen
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​Remark: WHO Calibration

Quantitative determination of total prostate specific antigen Remark: WHO Calibration

Quantitative determination of total prostate specific antigen

Need help finding instrument?

We will gladly assist you in making the right decision to achieve your business goals

Get a consultation
Need help finding instrument?